These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 26002423)

  • 61. The ACC/AHA and ESC/ESH Hypertension Guidelines: Contrasting Versions of Idiosyncratic Excellence.
    Flack JM; Calhoun D
    Am J Hypertens; 2019 Jul; 32(8):705-708. PubMed ID: 31314900
    [No Abstract]   [Full Text] [Related]  

  • 62. Optimizing hypertension management in clinical practice.
    Heagerty A
    J Hum Hypertens; 2006 Nov; 20(11):841-9. PubMed ID: 16915300
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Combination therapy with olmesartan medoxomil and hydrochlorothiazide: secondary analysis of the proportion of patients achieving recommended blood pressure goals from a randomized, double-blind, factorial study.
    Chrysant SG; Chavanu KJ; Xu J
    Am J Cardiovasc Drugs; 2009; 9(4):241-51. PubMed ID: 19655819
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine.
    Tocci G; Palano F; Pagannone E; Chin D; Ferrucci A; Volpe M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):115-23. PubMed ID: 19210207
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Blood pressure target attainment in the background of guidelines: the very elderly in Swiss primary care.
    Schäfer HH; Sudano I; Theus GR; Zilla P; Noll G; Burnier M
    Fam Pract; 2012 Oct; 29(5):511-20. PubMed ID: 22379186
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Managing hypertension: a question of STRATHE.
    Zannad F
    J Hum Hypertens; 2005 Jun; 19 Suppl 1():S3-7. PubMed ID: 16075031
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Use of fixed-dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia.
    Mahfoud F; Kieble M; Enners S; Kintscher U; Laufs U; Böhm M; Schulz M
    Clin Res Cardiol; 2023 Feb; 112(2):197-202. PubMed ID: 35220445
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Joint National Committee VII and European Society of Hypertension/European Society of Cardiology guidelines for evaluating and treating hypertension: a two-way road?
    Mancia G; Grassi G; ;
    J Am Soc Nephrol; 2005 Mar; 16 Suppl 1():S74-7. PubMed ID: 15938040
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Managing Treatment-Resistant Patients.
    Schmieder RE
    High Blood Press Cardiovasc Prev; 2015 Jul; 22 Suppl 1():S11-3. PubMed ID: 26025221
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The 2018 ESC/ESH hypertension guidelines: Should nephrologists always stop at the lower boundary?
    Reboldi G; Gentile G; Angeli F; Verdecchia P
    J Nephrol; 2018 Oct; 31(5):621-626. PubMed ID: 30168081
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Concordance of recommendations across clinical practice guidelines for the management of hypertension in Southeast Asia with internationally reputable sources.
    Kow CS; Hasan SS; Wong PS; Verma RK
    BMC Cardiovasc Disord; 2021 Jul; 21(1):354. PubMed ID: 34320925
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comments on 2018 ESC/ESH Hypertension Guidelines: Chinese Perspective.
    Zhang Y; Zhang W; Liu L
    Circ Res; 2019 Mar; 124(7):978-980. PubMed ID: 30920922
    [No Abstract]   [Full Text] [Related]  

  • 73. A step in the global effort to control hypertension: Fixed dose combination antihypertensive drugs.
    Campbell NRC
    J Clin Hypertens (Greenwich); 2019 Sep; 21(9):1426-1428. PubMed ID: 31441988
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The use of single-pill combinations as first-line treatment for hypertension: translating guidelines into clinical practice.
    Campana E; Cunha V; Glaveckaite S; Gruev I; Lamirault G; Lehmann E; Masi S; Mfeukeu Kuate L; Mishshenko L; Ona DID; Oo MZ; Tautu OGF; Vachulova A; Vintila AM; Wolf J; Zvartau N; Narkiewicz K; Laurent S
    J Hypertens; 2020 Dec; 38(12):2369-2377. PubMed ID: 32833920
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fixed-Dose Combination Medications for Treating Hypertension: A Review of Effectiveness, Safety, and Challenges.
    An J; Derington CG; Luong T; Olson KL; King JB; Bress AP; Jackevicius CA
    Curr Hypertens Rep; 2020 Oct; 22(11):95. PubMed ID: 33052522
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An observational study to evaluate factors responsible and actions taken for hypertensive patients who are not at blood pressure goal: i-target Goal Study.
    Aytekin S; Guneri S; Cam N; Aydinlar A; Kozdag G; Ozerkan F; Yigit Z; Birdane A
    Hypertens Res; 2012 Jun; 35(6):624-32. PubMed ID: 22318207
    [TBL] [Abstract][Full Text] [Related]  

  • 77. 2013 ESH/ESC guidelines for the management of arterial hypertension: what has changed in daily clinical practice?
    Liakos CI; Grassos CA; Babalis DK; ;
    High Blood Press Cardiovasc Prev; 2015 Mar; 22(1):43-53. PubMed ID: 25252743
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Therapy and guideline adherence at a multidisciplinary hypertension clinic: A prospective, observational study.
    Hias J; Defieuw L; Vanassche T; Verhamme P; Van der Linden L
    Vascul Pharmacol; 2024 Mar; 154():107271. PubMed ID: 38159830
    [TBL] [Abstract][Full Text] [Related]  

  • 79. New approach to blood pressure control: Triple combination pill.
    Volpe M; Gallo G; Tocci G
    Trends Cardiovasc Med; 2020 Feb; 30(2):72-77. PubMed ID: 30926237
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prevalence and determinants of resistant hypertension in a sample of patients followed in Italian hypertension centers: results from the MINISAL-SIIA study program.
    Galletti F; Barbato A;
    J Hum Hypertens; 2016 Nov; 30(11):703-708. PubMed ID: 26935287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.